Yahoo
HKSE - Delayed Quote HKD

Tianda Pharmaceuticals Limited (0455.HK)

0.089 0.000 (0.00%)
At close: October 27 at 3:46:48 PM GMT+8

Key Executives

Amounts are as of December 31, 2025 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in HKD.
Name Title Pay Exercised Year Born
Mr. Wen Quan Fang
Executive Chairman & MD 60k -- 1969
Mr. Man Sang Lui
Executive Director 72k -- 1964
Mr. Man Yuk Wong
Financial Controller -- -- --
Mr. Tai On Lo CPA
Company Secretary -- -- 1954

Tianda Pharmaceuticals Limited

CITIC Tower
24th Floor Suites 2405–2410 No. 1 Tim Mei Avenue
Central
Hong Kong
852 2545 3313 https://www.tiandapharma.com
Sector: 
Healthcare
Full Time Employees: 
573

Description

Tianda Pharmaceuticals Limited, together with its subsidiaries, engages in the research and development, manufacture, and sale of pharmaceutical, biotechnology, and healthcare products in Mainland China, Hong Kong, and Australia. It operates through the Chinese Medicine; Pharmaceuticals and Medical Technologies; and Medical and Healthcare Services segments. The company offers Chinese herbal medicine, Chinese medicine decoction pieces, Chinese medicine products, and Chinese medicine clinical services. It also produces pharmaceutical products focusing on cardiovascular and cerebrovascular medication, respiratory infections, and pediatric diseases. In addition, the company trades agricultural by-products. The company was formerly known as Tianda Holdings Limited and changed its name to Tianda Pharmaceuticals Limited in September 2012. The company was incorporated in 1992 and is headquartered in Central, Hong Kong. Tianda Pharmaceuticals Limited is a subsidiary of Tianda Group Limited.

Corporate Governance

Tianda Pharmaceuticals Limited’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

Recent Events

June 13, 2024 at 12:00 AM UTC

Ex-Dividend Date

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: